or Try an Advanced Search...

    Technical Analysis for IOBT - IO Biotech, Inc.

    Grade Last Price % Change Price Change
    D 1.50 -2.60% -0.04
    IOBT closed down 2.6 percent on Wednesday, May 8, 2024, on 24 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical IOBT trend table...
    Date Alert Name Type % Chg
    Fell Below 200 DMA Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Crossed Above 20 DMA Bullish -2.60%
    Crossed Above 200 DMA Bullish -2.60%
    Bollinger Band Squeeze Range Contraction -2.60%
    BB Squeeze + Upper Band Touch Range Contraction -2.60%
    Gapped Up Strength -2.60%
    Upper Bollinger Band Touch Strength -2.60%
    Older End-of-Day Signals for IOBT ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 19 hours ago
    Possible Inside Day about 19 hours ago
    20 DMA Support about 21 hours ago
    10 DMA Support about 21 hours ago
    Down 3% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IOBT Chart by TradingView
    Basic chart:

    Profile

    IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Immune System Treatment Of Cancer Cancer Therapies Anti Cancer Therapies Urea Cycle

    Is IOBT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Apr 15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
    Apr 9 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
    Apr 5 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
    Mar 7 IO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical Trials
    Mar 6 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    Mar 6 IO Biotech GAAP EPS of -$0.40 misses by $0.02
    Mar 5 IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
    Feb 26 IO Biotech to Present at 44th Annual Cowen Health Care Conference
    Jan 15 IO Biotech, Inc. (NASDAQ:IOBT) most popular amongst private equity firms who own 61% of the shares, institutions hold 24%
    See more IOBT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.28
    52 Week Low 0.8163
    Average Volume 85,504
    200-Day Moving Average 1.54
    50-Day Moving Average 1.60
    20-Day Moving Average 1.50
    10-Day Moving Average 1.49
    Average True Range 0.12
    RSI (14) 46.52
    ADX 17.36
    +DI 9.62
    -DI 8.82
    Chandelier Exit (Long, 3 ATRs) 1.29
    Chandelier Exit (Short, 3 ATRs) 1.75
    Upper Bollinger Bands 1.58
    Lower Bollinger Band 1.41
    Percent B (%b) 0.53
    BandWidth 11.30
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0108
    Fundamentals Value
    Market Cap 98.82 Million
    Num Shares 65.9 Million
    EPS -2.36
    Price-to-Earnings (P/E) Ratio -0.64
    Price-to-Sales 0.00
    Price-to-Book 0.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.67
    Resistance 3 (R3) 1.67 1.62 1.64
    Resistance 2 (R2) 1.62 1.58 1.62 1.63
    Resistance 1 (R1) 1.56 1.55 1.54 1.56 1.62
    Pivot Point 1.51 1.51 1.50 1.51 1.51
    Support 1 (S1) 1.45 1.47 1.43 1.45 1.38
    Support 2 (S2) 1.40 1.44 1.40 1.37
    Support 3 (S3) 1.34 1.40 1.36
    Support 4 (S4) 1.34